ANTI PHOSPHOLIPID ANTIBODY(APLA), IGM

Home Collection

Department: SEROLOGY

The Anti-Phospholipid Antibody (APLA) – IgM Test is a blood test used to detect IgM-type antibodies directed against phospholipids, which are essential components of cell membranes. These antibodies are part of a group known as antiphospholipid antibodies.

The APLA IgM Test is performed to:

• Diagnose Antiphospholipid-Syndrom.

• Assess the risk of abnormal blood clot formation

• Investigate recurrent pregnancy loss

• Support the diagnosis of autoimmune disorders

ANTI PHOSPHOLIPID ANTIBODY(APLA), IGM Test Purpose

The Anti Phospholipid Antibody (APLA), IgM Test is performed to detect IgM antiphospholipid antibodies in the blood. Primarily, the test is used to help diagnose Antiphospholipid Syndrome (APS), an autoimmune disorder that increases the risk of abnormal blood clot formation in arteries and veins. Additionally, it assists healthcare providers in evaluating individuals with unexplained blood clots, recurrent miscarriages, stillbirths, or other pregnancy-related complications. Furthermore, the test may be recommended as part of the evaluation for autoimmune diseases, particularly systemic lupus erythematosus (SLE) and related connective tissue disorders. Moreover, the APLA IgM Test is often performed alongside Anti Phospholipid Antibody IgG, Lupus Anticoagulant, Anti-Cardiolipin Antibodies, and Beta-2 Glycoprotein I Antibody Tests to provide a comprehensive assessment of antiphospholipid antibodies.

ANTI PHOSPHOLIPID ANTIBODY(APLA), IGM  Test is Recommended for Individuals:

• Individuals with suspected Antiphospholipid Syndrome (APS).
• Patients with unexplained blood clots in veins or arteries.
• Women with recurrent miscarriages, stillbirths, or other pregnancy-related complications.
• Individuals with suspected systemic lupus erythematosus (SLE) or other autoimmune diseases.
• Patients with unexplained stroke or transient ischemic attack (TIA) at a young age.
• Individuals undergoing evaluation for thrombophilia or clotting disorders.
• Patients with prolonged or unexplained abnormal clotting test results.
• Individuals referred by a rheumatologist, hematologist, or physician for autoimmune antibody testing.
• Anyone advised by their healthcare provider to assess the risk of autoimmune-related blood clotting disorders.

FAQs

1. What is the Anti Phospholipid Antibody (APLA), IgM Test used for?
The Anti Phospholipid Antibody (APLA), IgM Test detects IgM antiphospholipid antibodies. Additionally, it helps diagnose Antiphospholipid Syndrome (APS), assess the risk of abnormal blood clots, and investigate recurrent pregnancy loss.

2. Do I need to fast before the Anti Phospholipid Antibody (APLA), IgM Test?
No. Fasting is generally not required before this test. However, you should follow any preparation instructions provided by your healthcare provider.

3. What does a positive APLA IgM result indicate?
A positive result may indicate Antiphospholipid Syndrome (APS) or another autoimmune condition associated with an increased risk of blood clots. However, the results should always be interpreted alongside your symptoms, medical history, and additional laboratory findings by a healthcare professional.